Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Tutt

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|January 1, 1983
The export of immunoglobulin D by human neoplastic B lymphocytesF K Stevenson, G T Stevenson, A L Tutt
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1A J George, A L Tutt, F K Stevenson
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcomeJ Honeychurch, A Cruise, A L Tutt, et al.
Immunology|May 1, 1985
Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivoA L Tutt, F K Stevenson, S Slavin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibodyA L Tutt, R Reid, B S Wilkins, et al.
Methods in Molecular Medicine|February 22, 2011
The application of monoclonal antibodies in the treatment of lymphomaM J Glennie, J Honeychurch, R R French, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytesA L Tutt, F K Stevenson, J L Smith, et al.
Journal of Immunological Methods|September 28, 2010
Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serumF Chowdhury, A L Tutt, C Chan, et al.
Nature Medicine|May 6, 1999
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell helpR R French, H T Chan, A L Tutt, et al.
The Journal of Experimental Medicine|December 1, 1980
Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytesF K Stevenson, T J Hamblin, G T Stevenson, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|January 1, 1983
The export of immunoglobulin D by human neoplastic B lymphocytesF K Stevenson, G T Stevenson, A L Tutt
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1A J George, A L Tutt, F K Stevenson
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcomeJ Honeychurch, A Cruise, A L Tutt, et al.
Immunology|May 1, 1985
Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivoA L Tutt, F K Stevenson, S Slavin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibodyA L Tutt, R Reid, B S Wilkins, et al.
Methods in Molecular Medicine|February 22, 2011
The application of monoclonal antibodies in the treatment of lymphomaM J Glennie, J Honeychurch, R R French, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytesA L Tutt, F K Stevenson, J L Smith, et al.
Journal of Immunological Methods|September 28, 2010
Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serumF Chowdhury, A L Tutt, C Chan, et al.
Nature Medicine|May 6, 1999
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell helpR R French, H T Chan, A L Tutt, et al.
The Journal of Experimental Medicine|December 1, 1980
Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytesF K Stevenson, T J Hamblin, G T Stevenson, et al.
Pageof 3